Clinical Trials Directory

Trials / Conditions / Hyperactive Delirium

Hyperactive Delirium

8 registered clinical trials studyying Hyperactive Delirium — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingEffects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
NCT04824144
Bruyère Health Research Institute.Phase 1 / Phase 2
CompletedQuetiapine Versus Haloperidol in the Management of Hyperactive Delirium
NCT05690698
Alexandria UniversityPhase 3
WithdrawnValproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
NCT04513314
University of MiamiPhase 4
RecruitingHALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Ran
NCT04833023
Tan Tock Seng HospitalPhase 3
UnknownMindfulGarden in Treatment of Hyperactive Delirium in a Hospital Setting
NCT03621228
Simon Fraser UniversityN/A
UnknownDelirium Prevention in Patients From the Intensive Care Unit (DELA)
NCT03215745
Universidad de SantanderN/A
TerminatedValproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
NCT02343575
Stanford UniversityPhase 4
CompletedA Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)
NCT03954769
Stanford University—